期刊文献+

氮斯汀联合西米替丁治疗慢性荨麻疹疗效观察

下载PDF
导出
摘要 目的观察单独使用氮斯汀及联合西米替丁治疗慢性荨麻疹的疗效及不良反应。方法采用随机分组开放观察同样疗程单独使用氮斯汀(对照组)及联合西米替丁(治疗组)治疗慢性荨麻疹的疗效及不良反应。治疗组采用口服盐酸氮斯汀2 mg/d+西米替丁400 mg/d治疗,对照组采用口服盐酸氮斯汀4 mg/d,早晚各2 mg治疗。2组病例均连续服药4周后观察疗效和不良反应。结果 2组治疗效果和不良反应相似,差异无统计学意义。结论氮斯汀联合西米替丁治疗慢性荨麻疹,副作用并未显著增加,且减少了单用氮斯汀的用量,值得推广。
作者 孟复华
出处 《基层医学论坛》 2010年第34期1084-1085,共2页 The Medical Forum
  • 相关文献

参考文献3

二级参考文献27

  • 1Casale TB. The interaction of azelastine with human lung histamine H1, beta, and muscarinic receptor-binding sites. J Allergy Clin Immunol, 1989, 83 ( 4 ) : 771-776.
  • 2Chand N, Pillar J, Diamantis W, et al. Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs. Agents Actions, 1985, 16( 5 ) : 318-322.
  • 3Chand N, Pillar J, Diamantis W, et al. Effect of azelastine on activation and release stages of allergic histamine secretion in rabbit basophils. Res Commun Chem Pathol Pharmacol, 1991, 72( 1 ): 121-124.
  • 4Fields DA, Pillar J, Diamantis W, et al. Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells. J Allergy Clin Immunol, 1984, 73 ( 3 ) : 400-403.
  • 5Tamaoki J, Yamawaki I, Tagaya E, et al. Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. Am J Physiol, 1999, 276 ( 2 Pt 1 ) : L351-357.
  • 6Kempuraj D, H uang M, Kandere-Grzybowska K, et al. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells. Int Arch Allergy Immunol, 2003, 132 ( 3 ) : 231-239.
  • 7Kusters S, Sehuligoi R, Huttenbrink KB, et al. Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. Arzneimittelforschung, 2002, 52 ( 2 ) : 97-102.
  • 8Kempuraj D, Huang M, Kandere K, et al. Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells. Ann Allergy Asthma Immunol, 2002, 88 ( 5 ) : 501-506.
  • 9Camarasa JM, Aliaga A, Femandez-Vozmediano JM, et al. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. Skin Pharmacol Appl Skin Physiol, 2001, 14 ( 2 ) : 77-86.
  • 10Paul E, Riethmuller-Winzen H. Placebo-and verttm-controlled study in patients with chronic idiopathic uricaria. ASTA Medica Study Report A-05610/8800000097, 1994.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部